FOLD
Amicus Therapeutics Inc
NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY
$14.49
+0.00% today
Updated 2026-04-27
Market cap
$4.55B
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$6 – $15
Volume
3.5M
Amicus Therapeutics Inc (FOLD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+74.7%
Last 4 quarters
Revenue YoY growth
+23.7%
Most recent quarter
EPS YoY growth
+11.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+3.7%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $0.10 | +53.8% | $14.34 | $14.34 | +0.0% |
| 2025-11-04 | $0.06 | +100.0% | $8.86 | $9.19 | +3.7% |
| 2025-07-31 | $-0.08 | +27.3% | $6.13 | $6.32 | +3.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.07 | $0.10 | +53.8% | $185.21M | +23.7% |
| 2025-09-30 | $0.03 | $0.06 | +100.0% | $169.06M | +19.5% |
| 2025-06-30 | $-0.11 | $-0.08 | +27.3% | $154.69M | +22.1% |
| 2025-03-31 | $-0.07 | $0.03 | +142.9% | $125.25M | +13.4% |
| 2024-12-31 | $0.09 | $0.09 | -1.2% | $149.71M | +30.1% |
| 2024-09-30 | $-0.01 | $-0.02 | -100.0% | $141.52M | +36.7% |
| 2024-06-30 | $-0.06 | $-0.05 | +16.7% | $126.67M | +34.0% |
| 2024-03-31 | $-0.07 | $-0.16 | -128.6% | $110.40M | — |
| 2023-12-31 | $-0.06 | $-0.11 | -83.3% | $115.08M | — |
| 2023-09-30 | $-0.08 | $-0.07 | +12.5% | $103.50M | — |
| 2023-06-30 | $-0.12 | $-0.15 | -25.0% | $94.50M | — |
Frequently asked questions
Has Amicus Therapeutics Inc beaten earnings estimates?
Amicus Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +74.7% over the last 3 quarters.
How does FOLD stock react to earnings?
FOLD stock has moved an average of +2.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Amicus Therapeutics Inc's revenue growth rate?
Amicus Therapeutics Inc reported year-over-year revenue growth of +23.7% in its most recent quarter, with EPS growing +11.1% year-over-year.